登录新浪财经APP 搜索【信披】查看更多考评等级 股票代码：002727 股票简称：一心堂 公告编号：2025-096号 一心堂药业集团股份有限公司 关于使用部分暂时闲置自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 一心堂药业集团股份有限公司(以下简称"公司")于2025年5月21日召开2024年年度股东会，审议通过 《关于使用部分暂时闲置自有资金进行现金管理的议案》，同意公司及全资子公司使用额度不超过人民 币25亿元的闲置自有资金进行现金管理（包括但不限于购买一年期以内的固定收益型或保本浮动收益型 理财产品、大额存单、定期存款、通知存款、协定存款等），相关额度在投资期限内任一时点的现金管 理金额(含前述投资的收益进行再投资的相关金额)不超过25亿元人民币。在上述额度内，资金可以滚动 使用，在额度范围内授权董事长具体办理实施相关事项。 一、使用部分暂时闲置自有资金进行现金管理情况 （一）本次进行现金管理基本情况 近日，公司分别与华夏银行股份有限公司昆明红塔支行及广发银行股份有限公司昆明万宏支行签订了 《华夏银行人民币单位结构性 ...

Core Viewpoint - The company has redeemed its structured deposit product from Shanghai Pudong Development Bank, and the principal and interest income have been returned to the designated fundraising account [2] Group 1 - The company announced the redemption of a structured deposit product that was purchased using idle raised funds [2] - The principal and interest income from the structured deposit have been successfully returned to the fundraising account [2]

Group 1 - The company has approved the use of idle raised funds for cash management, with a maximum daily balance of 350 million yuan allocated for investment in safe and liquid principal-protected financial products [1] - The cash management plan allows for the rolling use of funds within a period not exceeding 12 months from the date of approval [1] - The company has redeemed a structured deposit product from Shanghai Pudong Development Bank, returning the principal and interest to the raised funds account, amounting to 90 million yuan [2]